Literature DB >> 15147217

Conformational substates of the oxyheme centers in alpha and beta subunits of hemoglobin as disclosed by EPR and ENDOR studies of cryoreduced protein.

Roman Davydov1, Viktoria Kofman, Judith M Nocek, Robert W Noble, Hilda Hui, Brian M Hoffman.   

Abstract

Exposure of frozen solutions of oxyhemoglobin to gamma-irradiation at 77 K yields EPR- and ENDOR-active, one-electron-reduced oxyheme centers which retain the conformation of the diamagnetic precursor. EPR spectra have been collected for the centers produced in human HbO(2) and isolated alphaO(2) and betaO(2) chains, as well as alphaO(2)beta(Zn), alpha(Zn)betaO(2), and alphaO(2)beta(Fe(3+)) hybrids, each in frozen buffer and in frozen glasses that form in the presence of glycols and sugars and also in the presence of IHP. These reveal two spectroscopically distinct classes of such ferriheme centers (g(1) <or= 2.25), denoted A and B. Averaged over many similar sites, the A-center has a rhombic EPR signal with a g-tensor, g(A) = [2.248(4), 2.146(1), 1.966(1)]; the B-center exhibits a less anisotropic EPR signal, g(B) = [2.216(3), 2.118(2), 1.966(1)]. Early measurement had suggested that, in the cryoreduced HbO(2) tetramer, the two centers corresponded to the two different chains [Symons, M. C. R., and Petersen, R. L. (1978) Proc. R. Soc. London, Ser. B 201, 285-300]. However, the present EPR and ENDOR results show that the two signals instead reflect the fact that the parent oxyhemes exist in two major conformational substates and that this is true for both alphaO(2) and betaO(2) subunits: alphaO(2)(A) (minor species) and alphaO(2)(B) (major species); betaO(2)(A)(major species) and betaO(2)(B) (minor species). Similar behavior is seen for MbO(2) [Kappl, R., Höhn-Berlage, M., Hüttermann, J., Bartlett, N., and Symons, M. C. R. (1985) Biochim. Biophys. Acta 827, 327-343]. The A/B g-tensors of alphaO(2) and betaO(2) chains vary little with the environment of the chains, while the relative populations of the substates depend greatly on glycols and IHP. These results suggest a quaternary influence on the oxyheme distal pocket of alpha chains and that the glycol-induced changes in the substate populations of the R-state HbO(2) tetramer are largely associated with the alphaO(2) subunit. (1)H ENDOR spectra from the distal histidine proton hydrogen-bonded to the peroxo ligand show very different isotropic coupling for the A- and B-centers. Analysis of the spectroscopic data suggests that the A- and B-centers represent different orientations of the oxyheme O(2) ligand relative to the distal histidine. It is likely that the A and B conformational substates in the alphaO(2) and betaO(2) subunits differ not only in their tertiary structures but in their affinities for O(2).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147217     DOI: 10.1021/bi036273z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Probing the oxyferrous and catalytically active ferryl states of Amphitrite ornata dehaloperoxidase by cryoreduction and EPR/ENDOR spectroscopy. Detection of compound I.

Authors:  Roman Davydov; Robert L Osborne; Muralidharan Shanmugam; Jing Du; John H Dawson; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2010-10-27       Impact factor: 15.419

2.  Reaction of the Co(II)-substrate radical pair catalytic intermediate in coenzyme B12-dependent ethanolamine ammonia-lyase in frozen aqueous solution from 190 to 217 K.

Authors:  Chen Zhu; Kurt Warncke
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

3.  Role of the Proximal Cysteine Hydrogen Bonding Interaction in Cytochrome P450 2B4 Studied by Cryoreduction, Electron Paramagnetic Resonance, and Electron-Nuclear Double Resonance Spectroscopy.

Authors:  Roman Davydov; Sangchoul Im; Muralidharan Shanmugam; William A Gunderson; Naw May Pearl; Brian M Hoffman; Lucy Waskell
Journal:  Biochemistry       Date:  2016-02-03       Impact factor: 3.162

Review 4.  Active intermediates in heme monooxygenase reactions as revealed by cryoreduction/annealing, EPR/ENDOR studies.

Authors:  Roman Davydov; Brian M Hoffman
Journal:  Arch Biochem Biophys       Date:  2010-09-18       Impact factor: 4.013

5.  Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.

Authors:  Roman Davydov; Andrey A Gilep; Natallia V Strushkevich; Sergey A Usanov; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2012-10-05       Impact factor: 15.419

6.  Comparison of the Mechanisms of Heme Hydroxylation by Heme Oxygenases-1 and -2: Kinetic and Cryoreduction Studies.

Authors:  Roman Davydov; Angela S Fleischhacker; Ireena Bagai; Brian M Hoffman; Stephen W Ragsdale
Journal:  Biochemistry       Date:  2015-12-23       Impact factor: 3.162

7.  Probing the ternary complexes of indoleamine and tryptophan 2,3-dioxygenases by cryoreduction EPR and ENDOR spectroscopy.

Authors:  Roman M Davydov; Nishma Chauhan; Sarah J Thackray; J L Ross Anderson; Nektaria D Papadopoulou; Christopher G Mowat; Stephen K Chapman; Emma L Raven; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2010-04-21       Impact factor: 15.419

8.  Characterization of the microsomal cytochrome P450 2B4 O2 activation intermediates by cryoreduction and electron paramagnetic resonance.

Authors:  Roman Davydov; Reza Razeghifard; Sang-Choul Im; Lucy Waskell; Brian M Hoffman
Journal:  Biochemistry       Date:  2008-08-13       Impact factor: 3.162

9.  The ferric-hydroperoxo complex of chloroperoxidase.

Authors:  Ilia G Denisov; John H Dawson; Lowell P Hager; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2007-10-01       Impact factor: 3.575

10.  Resonance Raman characterization of the peroxo and hydroperoxo intermediates in cytochrome P450.

Authors:  Ilia G Denisov; Piotr J Mak; Thomas M Makris; Stephen G Sligar; James R Kincaid
Journal:  J Phys Chem A       Date:  2008-12-18       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.